[Federal Register Volume 87, Number 219 (Tuesday, November 15, 2022)]
[Notices]
[Pages 68505-68506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24788]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Secretary's Advisory Council on Blood Stem 
Cell Transplantation (ACBSCT) has scheduled public meetings. 
Information about ACBSCT and the agenda for these meetings can be found 
on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.

DATES: 
     Monday, December 5, 2022, 12-4 p.m. Eastern Time; and
     Tuesday, December 6, 2022, 12-4 p.m. Eastern Time.

ADDRESSES: This meeting will be held virtually by webinar. A link to 
register and join the meeting will be posted at least 10 days prior to 
the meeting at https://bloodstemcell.hrsa.gov/about/advisory-council.

FOR FURTHER INFORMATION CONTACT: Shelley Grant, Designated Federal 
Official, at the HRSA's Health Systems Bureau, Division of 
Transplantation, 5600 Fishers Lane, 8W-67, Rockville, Maryland 20857; 
301-443-8036; or [email protected].

SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations 
to the Secretary of Health and Human Services (Secretary) on policy, 
program development, and other matters of significance concerning the 
activities under the authority of 42 U.S.C. Section 274k, Section 379 
of the Public Health Service Act, as amended, and Public Law 109-129, 
and as amended.
    During the December 5 and December 6, 2022, meetings, ACBSCT will 
discuss the impact of COVID-19 on blood stem cell donation and 
transplantation; unmet needs in blood stem cell transplantation and 
cellular therapy; strategies to improve rates of adult blood stem 
donation; and other areas to increase blood stem cell donation and 
transplantation. Agenda items are subject to change as priorities 
dictate. Refer to the ACBSCT website for any updated information 
concerning the meeting. Members of the public will have the opportunity 
to provide comments. Public participants may submit written statements 
in advance of the scheduled meetings; oral comments will be honored in 
the order they are requested and may be limited as time allows. 
Requests to submit a written statement or make oral comments to ACBSCT 
should be sent to Shelley Grant using the contact information above at 
least 3 business days prior to the meeting. Individuals who plan to

[[Page 68506]]

attend and need special assistance or another reasonable accommodation 
should notify ACBSCT at the address and phone number listed above at 
least 10 business days prior to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-24788 Filed 11-14-22; 8:45 am]
BILLING CODE 4165-15-P